LNCaP-NK1R and 22Rv1-NK1R demonstrated significant expression of NE marker CgA and ENO2 as well as the NE-related gene while the level of adenocarcinoma marker AR and PSA reduced (Fig. 4A and Fig. S3A). This evidence concerns the gene CGA and adenocarcinoma.